Please login to the form below

Not currently logged in
Email:
Password:

Inovio Biomedical elects new Board members

Inovio Biomedical Corporation has announced the election of David J Williams and Keith H Wells to its Board

DNA vaccine design, development and delivery firm Inovio Biomedical Corporation has announced the election of David J Williams, former chairman and CEO of Sanofi Pasteur, and Keith H Wells, a senior member of the Biologics Consulting Group and former director of vaccine development for The Salk Institute, to its Board. 

Dr J Joseph Kim, president and CEO of Inovio, said: "These two business leaders each have multiple decades of experience leading and executing the development and commercialisation of cutting-edge vaccine technology and important new vaccines. Their expertise will be invaluable to Inovio as we advance a new generation of vaccines – DNA vaccines delivered using the potency-enhancing capabilities of electroporation – that are displaying superior results and potential to not only prevent but treat challenging infectious diseases and cancers."

26th October 2009

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Solaris Health

The beauty of detail: an effective, compelling medical communications campaign requires each component to be carefully planned, expertly crafted and...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics